14
Feb
PSMA PET/CT Changes Management for Nearly Half of Prostate Cancer Patients
Imaging with 18F-DCFPyL PSMA PET/CT has been shown to considerably improve detection of ac...
Blog
11
Jul
Alzheimer’s Association Applauds CMS Decision to Cover PET Imaging for Alzheimer’s Disease Diagnosis
A valuable Alzheimer’s disease diagnostic tool will now be more accessible across the country thanks to a policy change today by the Centers for Medicare & Medicaid Services (CMS). The Alzheimer’s Association applauds CMS for taking action to expand coverage of brain amyloid positron emission tomography (PET) imaging for the diagnosis of Alzheimer’s disease.
07
Mar
Duran Duran’s Andy Taylor Says ‘Radioactive’ Cancer Drug May Extend His Life 5 Years
Duran Duran’s Andy Taylor was diagnosed with stage 4 prostate cancer in 2018 but is now “asymptomatic” after receiving a new and innovative cancer treatment. The musician was administered Lutetium-177, a type of radioactive treatment that targets cancer cells. In an interview with The Times, he said: “I was classified as palliative, end-of-life care. Now I’m not; I’m asymptomatic.”
21
Mar
Northern California PET Imaging Center Appoints Bradley Schmidt as Chief Executive Officer
Northern California PET Imaging Center, a global leader in precision cancer imaging using PET/CT Technology, announced the appointment of Bradley Schmidt as Chief Executive Officer.